Market Overview

AnaptysBio (NASDAQ: ANAB)

24.16 -0.42 (-1.71%)

Analyst Ratings

DateResearch FirmActionCurrentPT
10/27/20WedbushUpgradesOutperform35.0
10/14/20GuggenheimUpgradesBuy36.0
5/07/20Credit SuisseMaintainsNeutral16.0
3/03/20SunTrust Robinson HumphreyMaintainsHold14.0
11/08/19GuggenheimDowngradesNeutral
10/03/19Credit SuisseMaintainsNeutral48.0
8/09/19Credit SuisseMaintainsNeutral75.0
6/24/19SunTrust Robinson HumphreyMaintainsBuy93.0
6/21/19Credit SuisseDowngradesNeutral
2/22/19GuggenheimInitiates Coverage OnBuy

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter